questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines membranaires
Protéines du transport vésiculaire
Protéines SNARE
Protéines Q-SNARE
Protéines Qb-SNARE
Protéines Qb-SNARE : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Protéines Qb-SNARE
Diagnostic médical
Protéines Qb-SNARE
Immunoblot
Protéines Qb-SNARE
Tests génétiques
Protéines Qb-SNARE
Biomarqueurs
Protéines Qb-SNARE
Troubles neurologiques
Symptômes
5
Protéines Qb-SNARE
Déficits cognitifs
Protéines Qb-SNARE
Troubles neurologiques
Protéines Qb-SNARE
Anomalies comportementales
Protéines Qb-SNARE
Types cellulaires
Protéines Qb-SNARE
Troubles de la motricité
Prévention
5
Protéines Qb-SNARE
Prévention
Protéines Qb-SNARE
Dépistage génétique
Protéines Qb-SNARE
Éducation génétique
Protéines Qb-SNARE
Habitudes alimentaires
Protéines Qb-SNARE
Stress
Traitements
5
Protéines Qb-SNARE
Thérapie médicamenteuse
Protéines Qb-SNARE
Thérapie génique
Protéines Qb-SNARE
Médicaments
Protéines Qb-SNARE
Rééducation
Protéines Qb-SNARE
Médecine personnalisée
Complications
5
Protéines Qb-SNARE
Complications neurologiques
Protéines Qb-SNARE
Réversibilité
Protéines Qb-SNARE
Maladie d'Alzheimer
Protéines Qb-SNARE
Qualité de vie
Protéines Qb-SNARE
Complications psychologiques
Facteurs de risque
5
Protéines Qb-SNARE
Facteurs de risque
Protéines Qb-SNARE
Vieillissement
Protéines Qb-SNARE
Antécédents familiaux
Protéines Qb-SNARE
Toxines environnementales
Protéines Qb-SNARE
Mode de vie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines Qb-SNARE : Questions médicales les plus fréquentes",
"headline": "Protéines Qb-SNARE : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines Qb-SNARE : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-22",
"dateModified": "2025-04-18",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines Qb-SNARE"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines Q-SNARE",
"url": "https://questionsmedicales.fr/mesh/D050682",
"about": {
"@type": "MedicalCondition",
"name": "Protéines Q-SNARE",
"code": {
"@type": "MedicalCode",
"code": "D050682",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.543.990.775.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Protéines Qb-SNARE",
"alternateName": "Qb-SNARE Proteins",
"code": {
"@type": "MedicalCode",
"code": "D050766",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Haijia Yu",
"url": "https://questionsmedicales.fr/author/Haijia%20Yu",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Electronic address: yuhaijia@njnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Yinghui Liu",
"url": "https://questionsmedicales.fr/author/Yinghui%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Electronic address: yinghuiliu@njnu.edu.cn."
}
},
{
"@type": "Person",
"name": "Reinhard Jahn",
"url": "https://questionsmedicales.fr/author/Reinhard%20Jahn",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Neurobiology, Max-Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. rjahn@mpinat.mpg.de."
}
},
{
"@type": "Person",
"name": "Min Zhu",
"url": "https://questionsmedicales.fr/author/Min%20Zhu",
"affiliation": {
"@type": "Organization",
"name": "Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China."
}
},
{
"@type": "Person",
"name": "Lukas K Tamm",
"url": "https://questionsmedicales.fr/author/Lukas%20K%20Tamm",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Characteristics of deceleration capacity and deceleration runs in vasovagal syncope.",
"datePublished": "2023-09-30",
"url": "https://questionsmedicales.fr/article/37776375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10286-023-00989-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Using a penalized likelihood to detect mortality deceleration.",
"datePublished": "2023-11-16",
"url": "https://questionsmedicales.fr/article/37972099",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0294428"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intrapartum deceleration and acceleration areas are associated with neonatal encephalopathy.",
"datePublished": "2023-01-09",
"url": "https://questionsmedicales.fr/article/36572017",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ijgo.14638"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma myoglobin indicates muscle damage associated with acceleration/deceleration during football.",
"datePublished": "2023-09-15",
"url": "https://questionsmedicales.fr/article/37712927",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.23736/S0022-4707.23.15203-0"
}
},
{
"@type": "ScholarlyArticle",
"name": "The association of intrapartum deceleration and acceleration areas with MRI findings in neonatal encephalopathy.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/36964444",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41390-023-02575-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines membranaires",
"item": "https://questionsmedicales.fr/mesh/D008565"
},
{
"@type": "ListItem",
"position": 5,
"name": "Protéines du transport vésiculaire",
"item": "https://questionsmedicales.fr/mesh/D033921"
},
{
"@type": "ListItem",
"position": 6,
"name": "Protéines SNARE",
"item": "https://questionsmedicales.fr/mesh/D050600"
},
{
"@type": "ListItem",
"position": 7,
"name": "Protéines Q-SNARE",
"item": "https://questionsmedicales.fr/mesh/D050682"
},
{
"@type": "ListItem",
"position": 8,
"name": "Protéines Qb-SNARE",
"item": "https://questionsmedicales.fr/mesh/D050766"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines Qb-SNARE - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines Qb-SNARE",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines Qb-SNARE",
"description": "Comment diagnostiquer une dysfonction des protéines Qb-SNARE ?\nQuels tests sont utilisés pour évaluer les protéines Qb-SNARE ?\nLes tests génétiques sont-ils nécessaires pour les protéines Qb-SNARE ?\nQuels biomarqueurs sont associés aux protéines Qb-SNARE ?\nY a-t-il des symptômes cliniques liés aux protéines Qb-SNARE ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines Qb-SNARE",
"description": "Quels symptômes indiquent une anomalie des protéines Qb-SNARE ?\nLes troubles neurologiques sont-ils liés aux protéines Qb-SNARE ?\nPeut-on observer des anomalies comportementales ?\nLes symptômes varient-ils selon le type de cellule ?\nY a-t-il des signes cliniques spécifiques ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines Qb-SNARE",
"description": "Peut-on prévenir les dysfonctionnements des Qb-SNARE ?\nY a-t-il des mesures préventives spécifiques ?\nL'éducation génétique est-elle utile ?\nLes habitudes alimentaires influencent-elles ?\nLe stress a-t-il un impact sur ces protéines ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines Qb-SNARE",
"description": "Quels traitements sont disponibles pour les dysfonctionnements des Qb-SNARE ?\nLa thérapie génique est-elle une option ?\nDes médicaments spécifiques existent-ils ?\nLa rééducation est-elle efficace ?\nLes traitements sont-ils personnalisés ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines Qb-SNARE",
"description": "Quelles complications peuvent survenir avec les Qb-SNARE ?\nLes complications sont-elles réversibles ?\nY a-t-il des risques de maladies associées ?\nLes complications affectent-elles la qualité de vie ?\nDes complications psychologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines Qb-SNARE",
"description": "Quels sont les facteurs de risque pour les dysfonctionnements des Qb-SNARE ?\nL'âge est-il un facteur de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nL'exposition à des toxines influence-t-elle le risque ?\nLe mode de vie influence-t-il le risque ?",
"url": "https://questionsmedicales.fr/mesh/D050766?mesh_terms=Deceleration#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction des protéines Qb-SNARE ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests génétiques et des analyses protéomiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer les protéines Qb-SNARE ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests d'immunoblot et des analyses de microscopie électronique sont courants."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils nécessaires pour les protéines Qb-SNARE ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations affectant ces protéines."
}
},
{
"@type": "Question",
"name": "Quels biomarqueurs sont associés aux protéines Qb-SNARE ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des biomarqueurs comme la syntaxine peuvent être mesurés pour évaluer leur fonction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cliniques liés aux protéines Qb-SNARE ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques et des anomalies de transport intracellulaire peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une anomalie des protéines Qb-SNARE ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles de la communication cellulaire, des déficits cognitifs et moteurs peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Les troubles neurologiques sont-ils liés aux protéines Qb-SNARE ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent résulter de dysfonctionnements de ces protéines."
}
},
{
"@type": "Question",
"name": "Peut-on observer des anomalies comportementales ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies comportementales peuvent être observées en cas de dysfonction des Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de cellule ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier selon le type cellulaire affecté par la dysfonction."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cliniques spécifiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des troubles de la motricité fine peuvent être spécifiques à ces anomalies."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les dysfonctionnements des Qb-SNARE ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives spécifiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des mesures comme le dépistage génétique peuvent aider à identifier les risques."
}
},
{
"@type": "Question",
"name": "L'éducation génétique est-elle utile ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation sur les risques génétiques peut aider à la prise de décision éclairée."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé cellulaire et potentiellement réduire les risques."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur ces protéines ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress chronique peut affecter la fonction cellulaire, y compris celle des Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les dysfonctionnements des Qb-SNARE ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements ciblent souvent les symptômes, comme la rééducation et la thérapie médicamenteuse."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour corriger les mutations des protéines Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Des médicaments spécifiques existent-ils ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de médicaments spécifiques ciblant directement les Qb-SNARE."
}
},
{
"@type": "Question",
"name": "La rééducation est-elle efficace ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la rééducation peut aider à améliorer les fonctions motrices et cognitives."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent être personnalisés en fonction des symptômes et des besoins du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les Qb-SNARE ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques graves, comme des troubles neurodégénératifs, peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais beaucoup ne sont pas réversibles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies associées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la maladie d'Alzheimer peuvent être associées à des dysfonctionnements des Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Des complications psychologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des complications psychologiques comme l'anxiété peuvent être liées à ces dysfonctionnements."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les dysfonctionnements des Qb-SNARE ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des prédispositions génétiques et des facteurs environnementaux."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le vieillissement peut augmenter le risque de dysfonctionnement des protéines Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux jouent-ils un rôle ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de troubles neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines influence-t-elle le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à certaines toxines environnementales peut affecter la fonction des Qb-SNARE."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 18/04/2025
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Electronic address: yuhaijia@njnu.edu.cn.
Publications dans "Protéines Qb-SNARE" :
4 publications dans cette catégorie
Affiliations :
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Electronic address: yinghuiliu@njnu.edu.cn.
Publications dans "Protéines Qb-SNARE" :
3 publications dans cette catégorie
Affiliations :
Laboratory of Neurobiology, Max-Planck Institute for Multidisciplinary Sciences, Göttingen, Germany. rjahn@mpinat.mpg.de.
Publications dans "Protéines Qb-SNARE" :
3 publications dans cette catégorie
Affiliations :
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Physiology and Biological Physics, University of Virginia, Charlottesville, VA, USA.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, China.
Department of Biosciences, Durham University, Durham, UK.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Ministry of Education Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Biosciences, Durham University, Durham, UK.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Shenzhen Key Laboratory of Microbial Genetic Engineering, College of Life Sciences and Oceanography, Shenzhen University, Shenzhen 518060, China.
College of Physics and Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Xinjiang Key Laboratory of Desert Plant Roots Ecology and Vegetation Restoration, Xinjiang Institute of Ecology and Geography, Chinese Academy of Sciences, Urumqi 830011, China.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Institute of Physiological Chemistry, Technische Universität Dresden, Dresden, Germany.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Institute of Physiological Chemistry, Technische Universität Dresden, Dresden, Germany.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. Electronic address: jiajie.diao@uc.edu.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA.
Publications dans "Protéines Qb-SNARE" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder, CO 80309, USA. Electronic address: jingshi.shen@colorado.edu.
Publications dans "Protéines Qb-SNARE" :
1 publication dans cette catégorie
Affiliations :
College of Information and Computer Engineering, Northeast Forestry University, Harbin, China.
Publications dans "Protéines Qb-SNARE" :
Increased vagal activity plays a prominent role in vasovagal syncope (VVS). The aim of this study was to characterize vagal function in VVS by evaluating the heart rate (HR) deceleration capacity (DC)...
A total of 188 consecutive VVS patients were enrolled in the study, of whom 129 had positive head-up tilt test (HUTT); 132 healthy participants were enrolled as controls. DC, DRs (DR2, i.e., episodes ...
Patients with VVS had higher DC (10.63 ± 2.1 vs. 6.58 ± 1.7 ms; P < 0.001) and lower minimum HR and DR6-10 than controls. No significant differences in DC or DR6-10 were found between the patients wit...
Compared to healthy controls, patients with VVS demonstrated distinct HR deceleration profiles between attacks, including overall higher DC and lower DR6-10....
We suggest a novel method for detecting mortality deceleration by adding a penalty to the log-likelihood function in a gamma-Gompertz setting. This is an alternative to traditional likelihood inferenc...
To investigate whether an association exists between deceleration and acceleration areas on continuous fetal cardiotocography (CTG) and neonatal encephalopathy (NE)....
A single center, retrospective case-control study was conducted to compare CTG characteristics of low-risk pregnancies (35 weeks of gestation or more), complicated by moderate to severe NE with two ma...
During the period between 2013 and 2019, we identified 95 cases of low-risk pregnancies that were complicated by moderate to severe NE in our center. Thirty-three (34.7%) deliveries were excluded, mos...
NE was significantly associated with increased total deceleration area, decreased total acceleration area, and a lower acceleration-to-deceleration ratio, independent of cord blood pH. Development of ...
Monitoring muscle damage in athletes assists not only coaches to adjust the training workload but also medical staff to prevent injury. Measuring blood myoglobin concentration can help evaluate muscle...
Whole blood samples from participants' fingertips were collected before the match (baseline) and at 2, 16, and 40 h after the match. Myoglobin concentrations were measured using the IA-100 compact imm...
The mean myoglobin concentration was significantly higher at 2 h than at the other time points (P<0.05), and decreased to baseline levels within 16 h post-match. The mean creatine kinase concentration...
Our findings indicate that myoglobin is a more sensitive marker of muscle damage than creatine kinase after football match-play. Monitoring myoglobin in athletes can aid in determining their recovery ...
Hypoxic-ischemic encephalopathy (HIE) is an important contributor to disability worldwide. The current cardiotocography (CTG) predictive value for neonatal outcome is limited....
To assess the association of intrapartum CTG deceleration and acceleration areas with early MRI cerebral pathology in infants with HIE....
Term and near-term low-risk pregnancies that resulted in HIE, treated with therapeutic hypothermia with sufficient CTG records from a single, tertiary hospital between 2013 and 2021 were enrolled. Acc...
A total of 77 infants were included in the final analysis. Significant associations between increased total acceleration area (p = 0.007) and between a higher acceleration-to-deceleration area ratio (...
In neonates treated for HIE, acceleration area and acceleration-to-deceleration ratio are associated with the risk of neonatal brain MRI abnormalities. To increase the role of these measurements as a ...
The current cardiotocography predictive value for neonatal outcome is limited. This study aimed to assess the association of intrapartum deceleration and acceleration areas with the degree of cerebral...
The aim of this review is to summarize the current scientific knowledge about acceleration and deceleration demands during football training....
A systematic search of three electronic databases (PubMed, SPORTDiscus, Web of Science) was performed to identify peer-reviewed relevant English-language articles, following PRISMA guidelines....
All acceleration and deceleration data were analyzed and organized into four categories: i) training drills variables (i.e. manipulated drills variables such as number of players in small-sided games)...
Different exercises elicit different demands and small-sided games presented higher acceleration and deceleration demands than circuit training and other running based drills. Furthermore, manipulatin...
Modern societies provide an abundance of opportunities, which could lead to acceleration and time poverty, thereby paradoxically limiting well-being. This study examines this issue using social distan...
This study aimed to investigate the acute effects of lower limb wearable resistance on maximal horizontal deceleration biomechanics, across two different assessments. Twenty recreationally trained tea...
A new functional mapping strategy based on targeting deceleration zones (DZs) has become one of the most commonly used strategies within the armamentarium of substrate-based ablation methods for ventr...
The purpose of this study was to analyze the evolution of DZs during ablation and their correlation with CMR....
Forty-two consecutive patients with scar-related VT undergoing ablation after CMR in Hospital Clinic (October 2018-December 2020) were included (median age 65.3 ± 11.8 years; 94.7% male; 73.7% ischemi...
Overall, 95 DZs were analyzed, 93.68% of which were correlated with CMR-CCs: 44.8% located in the middle segment and 55.2% located in the entrance/exit of the channel. Remapping was performed in 91.7%...
DZs are highly correlated with CMR-CCs. In addition, remapping can lead to the identification of hidden substrate initially not identified by electroanatomic mapping but detected by CMR....
Deceleration is considered a commonly practised means to assess Foetal Heart Rate (FHR) through visual inspection and interpretation of patterns in Cardiotocography (CTG). The precision of deceleratio...